New horizons in immunotherapy

CELL AND GENE THERAPY INSIGHTS

New horizons in immunotherapy

August 2023
New horizons in immunotherapy
Download PDF

Editorial

European research infrastructures join forces to provide innovative cancer research services across Europe—how can they support the cell and gene therapy developer?

European research infrastructures join forces to provide innovative cancer research services across Europe—how can they support the cell and gene therapy developer?

E Oldoni, P Carvajal-Vallejos, F Bietrix et al.
10 August 2023
Read

Expert Insight

Harnessing chimeric antigen receptor (CAR)-T cells as a potential treatment for Alzheimer’s disease

Harnessing chimeric antigen receptor (CAR)-T cells as a potential treatment for Alzheimer’s disease

Lauren Sarko, Krishanu Saha
13 September 2023
Read

Viewpoint

iNKT cells for allogeneic cell therapy

iNKT cells for allogeneic cell therapy

Eleni Chantzoura, Paul Ibbett
30 August 2023
Read

Interview

Developing universal AAV immuno-gene therapy for oncology

Developing universal AAV immuno-gene therapy for oncology

Nicole Paulk
23 August 2023
Read
Does synthetic biology hold the key to unlocking solid tumors for cell and gene therapy?

Does synthetic biology hold the key to unlocking solid tumors for cell and gene therapy?

Ming-Ru Wu
20 August 2023
Read
Rearming the immune system with personalized allogeneic CAR-T cell therapy

Rearming the immune system with personalized allogeneic CAR-T cell therapy

Olivier Negre
17 August 2023
Read
Increasing patient access to cellular immunotherapy through RNA gene writing

Increasing patient access to cellular immunotherapy through RNA gene writing

Madhusudan Peshwa
4 August 2023
Read

Webinars

Expand your T cell manufacturing capacities in an automated, closed system to shorten your production time

Expand your T cell manufacturing capacities in an automated, closed system to shorten your production time

Sophia Lollies, Ian Johnston
31 August 2023
Watch